ezetimibe has been researched along with stigmastanol in 4 studies
| Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (stigmastanol) | Trials (stigmastanol) | Recent Studies (post-2010) (stigmastanol) |
|---|---|---|---|---|---|
| 2,484 | 563 | 1,465 | 139 | 31 | 29 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hazen, SL; Sehayek, E | 1 |
| Constantinides, PP; Darlington, J; Gershkovich, P; Sivak, O; Wasan, KM | 1 |
| Masuda, D; Nakagawa-Toyama, Y; Nishida, M; Ohama, T; Tsubakio-Yamamoto, K; Yamashita, S | 1 |
| DeBarber, AE; Jones, PJH; Mymin, D; Myrie, SB; Othman, RA; Roullet, JB; Steiner, RD | 1 |
1 review(s) available for ezetimibe and stigmastanol
| Article | Year |
|---|---|
Current therapy for patients with sitosterolemia--effect of ezetimibe on plant sterol metabolism.
Topics: Adolescent; Anticholesteremic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 5; ATP-Binding Cassette Transporters; Azetidines; Bile Acids and Salts; Cardiovascular Diseases; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ileum; Ion Exchange Resins; Lipid Metabolism, Inborn Errors; Lipoproteins; Male; Models, Biological; Mutation, Missense; Phytosterols; Sitosterols; Young Adult | 2010 |
1 trial(s) available for ezetimibe and stigmastanol
| Article | Year |
|---|---|
Thyroid Hormone Status in Sitosterolemia Is Modified by Ezetimibe.
Topics: Adolescent; Adult; Anticholesteremic Agents; Cholestanol; Cholestenones; Cholesterol; Ezetimibe; Female; Humans; Hypercholesterolemia; Intestinal Diseases; Lipid Metabolism, Inborn Errors; Male; Middle Aged; Phytosterols; Sitosterols; Thyrotropin; Thyroxine; Triiodothyronine; Young Adult | 2017 |
2 other study(ies) available for ezetimibe and stigmastanol
| Article | Year |
|---|---|
Cholesterol absorption from the intestine is a major determinant of reverse cholesterol transport from peripheral tissue macrophages.
Topics: Animals; Anticholesteremic Agents; Azetidines; Cell Line; Cell Transplantation; Cholesterol, Dietary; Ezetimibe; Feces; Female; Intestinal Absorption; Intestines; Kinetics; Lipid Metabolism; Macrophages; Mice; Mice, Congenic; Mice, Inbred C57BL; Sitosterols | 2008 |
Inhibition of intestinal absorption of cholesterol by surface-modified nanostructured aluminosilicate compounds.
Topics: Aluminum Silicates; Animals; Anticholesteremic Agents; Azetidines; Cholesterol; Ezetimibe; Intestinal Absorption; Male; Nanostructures; Particle Size; Protons; Rats; Rats, Sprague-Dawley; Sitosterols; Surface Properties; Viscosity | 2009 |